Erez a proprietary indica-dominant strain that is high in THC, the compound in cannabis responsible for its psychoactive properties, and low in CBD. Patients report that Erez may help with sleep disorders, pain, nausea, and appetite. It is recommended for experienced cannabis users, accustomed to higher levels of THC.
Erez was licensed to Jay Pharma for pharmaceutical and over-the-counter use in cancer indications outside of Israel. Jay Pharma plans to use data collected from patients who are using, or have used, Erez to guide future surveillance studies and/or clinical development efforts.